Skip to content

Disc Medicine IRON Other operating expenses

Other operating expenses at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$200K
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
$60.02M+26.0%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$227.59M+10.6%

Other financials

Income statement

See full
Operating income-$69.5M-74.0%
Net income-$63.5M-86.3%
EPS (diluted)-$1.65-61.8%

Balance sheet

See full
Cash & equivalents$88.9M-27.5%
Total debt$31.1M+1.4%
Total equity$688.4M+4.3%
Total assets$750.2M+5.8%

Cash flow

See full
Operating cash flow-$62.2M-50.4%
CapEx--100%
Free cash flow-$62.2M-47.4%

Valuation

See full
Market cap$2.69B+42.2%
Enterprise value$2.63B+46.7%

Returns & leverage

See full
Return on equity-35.8%+41.3pp
Debt / equity0.0×
Current ratio24×-13.6×

Where this comes from

Reported directly by Disc Medicine in its filing.

Tagged under the XBRL concept us-gaap:OperatingExpenses.

The official record: Disc Medicine’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Disc Medicine's other operating expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Disc Medicine's other operating expenses?
Disc Medicine (IRON) reported other operating expenses of $69.52M in Q1 2026.
How has Disc Medicine's other operating expenses changed year-over-year?
Disc Medicine's other operating expenses increased by 74.0% year-over-year, from $39.95M to $69.52M.
What is the long-term trend for Disc Medicine's other operating expenses?
Over 3 years (2022 to 2025), Disc Medicine's other operating expenses has grown at a 70.7% compound annual growth rate (CAGR), from $47.48M to $236.02M.
What does other operating expenses mean?
Residual operating expenses not classified into specific categories, serving as a catch-all for miscellaneous operating costs.